Role of translocation in the activation and function of protein kinase B
- PMID: 9395488
- DOI: 10.1074/jbc.272.50.31515
Role of translocation in the activation and function of protein kinase B
Abstract
We have investigated the role of subcellular localization in the regulation of protein kinase B (PKB) activation. The myristoylation/palmitylation motif from the Lck tyrosine kinase was attached to the N terminus of protein kinase B to alter its subcellular location. Myristoylated/palmitylated (m/p)-PKBalpha was associated with the plasma membrane of transfected cells, whereas the wild-type kinase was mostly cytosolic. The activity of m/p-PKBalpha was 60-fold higher compared with the unstimulated wild-type enzyme, and could not be stimulated further by growth factors or phosphatase inhibitors. In vivo 32P labeling and mutagenesis demonstrated that m/p-PKBalpha activity was due to phosphorylation on Thr308 and Ser473, that are normally induced on PKB following stimulation of the cells with insulin or insulin-like growth factor-1 (IGF-1). A dominant negative form of phosphoinositide 3-kinase (PI3-K) did not affect m/p-PKBalpha activity. The pleckstrin homology (PH) domain of m/p-PKBalpha was not required for its activation or phosphorylation on Thr308 and Ser473, suggesting that this domain may serve as a membrane-targeting module. Consistent with this view, PKBalpha was translocated to the plasma membrane within minutes after stimulation with IGF-1. This translocation required the PH domain and was sensitive to wortmannin. Our results indicate that PI3-K activity is required for translocation of PKB to the plasma membrane, where its activation occurs through phosphorylation of the same sites that are induced by insulin or IGF-1. Following activation the kinase detached from the membrane and translocated to the nucleus.
Similar articles
-
Tumour necrosis factor-alpha activation of protein kinase B in WEHI-164 cells is accompanied by increased phosphorylation of Ser473, but not Thr308.Biochem J. 2001 Oct 1;359(Pt 1):119-27. doi: 10.1042/0264-6021:3590119. Biochem J. 2001. PMID: 11563975 Free PMC article.
-
Mechanism of activation of protein kinase B by insulin and IGF-1.EMBO J. 1996 Dec 2;15(23):6541-51. EMBO J. 1996. PMID: 8978681 Free PMC article.
-
Involvement of the phosphoinositide 3-kinase/protein kinase B signaling pathway in insulin/IGF-I-induced chondrogenesis of the mouse embryonal carcinoma-derived cell line ATDC5.Int J Biochem Cell Biol. 2001 Nov;33(11):1094-103. doi: 10.1016/s1357-2725(01)00067-x. Int J Biochem Cell Biol. 2001. PMID: 11551825
-
Distinct activation mechanisms of protein kinase B by growth-factor stimulation and heat-shock treatment.Biochemistry. 2004 Apr 13;43(14):4284-93. doi: 10.1021/bi0498712. Biochemistry. 2004. PMID: 15065872
-
Mechanism of protein kinase B activation by insulin/insulin-like growth factor-1 revealed by specific inhibitors of phosphoinositide 3-kinase--significance for diabetes and cancer.Pharmacol Ther. 1999 May-Jun;82(2-3):409-25. doi: 10.1016/s0163-7258(98)00071-0. Pharmacol Ther. 1999. PMID: 10454216 Review.
Cited by
-
Overview of carboxyl‑terminal modulator protein 1 and its importance in various metabolic regulations (Review).Mol Med Rep. 2024 Sep;30(3):158. doi: 10.3892/mmr.2024.13282. Epub 2024 Jul 12. Mol Med Rep. 2024. PMID: 38994770 Free PMC article. Review.
-
Metabolomics Approach Reveals Important Glioblastoma Plasma Biomarkers for Tumor Biology.Int J Mol Sci. 2023 May 16;24(10):8813. doi: 10.3390/ijms24108813. Int J Mol Sci. 2023. PMID: 37240159 Free PMC article.
-
Delivery of Active AKT1 to Human Cells.Cells. 2022 Nov 29;11(23):3834. doi: 10.3390/cells11233834. Cells. 2022. PMID: 36497091 Free PMC article.
-
Targeting mTOR as a Cancer Therapy: Recent Advances in Natural Bioactive Compounds and Immunotherapy.Cancers (Basel). 2022 Nov 10;14(22):5520. doi: 10.3390/cancers14225520. Cancers (Basel). 2022. PMID: 36428613 Free PMC article. Review.
-
Role of PI3K/Akt/mTOR pathway in mediating endocrine resistance: concept to clinic.Explor Target Antitumor Ther. 2022;3(2):172-199. doi: 10.37349/etat.2022.00078. Epub 2022 Apr 24. Explor Target Antitumor Ther. 2022. PMID: 36046843 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous